Exploring the metabolic profiling of for antimicrobial development using genome-scale modelling

Nantia Leonidou,Yufan Xia,Lea Friedrich,Monika S. Schütz,Andreas Dräger
DOI: https://doi.org/10.1101/2023.09.13.557502
2024-02-07
Abstract:With the emergence of multidrug-resistant bacteria, the World Health Organization published a catalog of microorganisms urgently needing new antibiotics, with the carbapenem-resistant designated as “critical”. Such isolates, frequently detected in healthcare settings, pose a global pandemic threat. One way to facilitate a systemic view of bacterial metabolism and allow the development of new therapeutics is to apply constraint-based modelling. Here, we developed a versatile workflow to build high-quality and simulation-ready genome-scale metabolic models. We applied our workflow to create a novel metabolic model for and validated its predictive capabilities using experimental nutrient utilization and gene essentiality data. Our analysis showed that our model ACB23LX could recapitulate cellular metabolic phenotypes observed during experiments, while positive biomass production rates were observed and experimentally validated in various growth media. We further defined a minimal set of compounds that increase ‘s cellular biomass and identified putative essential genes with no human counterparts, offering novel candidates for future antimicrobial development. Finally, we assembled and curated the first collection of reconstructions for distinct strains and analysed their growth characteristics. The presented models are in a standardised and well-curated format, enhancing their usability for multi-strain network reconstruction.
Systems Biology
What problem does this paper attempt to address?